$0.81
+0.00 (+0.41%)
Open$0.85
Previous Close$0.81
Day High$0.85
Day Low$0.81
52W High$1.19
52W Low$0.54
Volume—
Avg Volume143.1K
Market Cap9.97M
P/E Ratio—
EPS$-1.84
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+5,372.2% upside
Current
$0.81
$0.81
Target
$44.56
$44.56
$28.75
$44.56 avg
$50.07
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 83.30M | 72.01M | 1.67M |
| Net Income | -39,641,119 | -30,838,453 | 470.0K |
| Profit Margin | -47.6% | -45.2% | 28.1% |
| EBITDA | -34,811,882 | -28,586,124 | 856.8K |
| Free Cash Flow | — | — | 585.2K |
| Rev Growth | +15.7% | +15.7% | +24.3% |
| Debt/Equity | 0.92 | 0.92 | 0.16 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |